Related Experiment Video

Updated: Jul 3, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

[Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells]

Xia Li1, Hua-Yu Deng

  • 1Department of Pathophysiology, Chongqing Medical University, Chongqing 400016, China.

Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition
|July 18, 2008
PubMed
Abstract

Insights

Inhibiting heat shock protein 90 (Hsp90) with geldanamycin (GA) reduces telomerase activity and mutant P53 expression in human breast cancer cells. This inhibition also represses cancer cell proliferation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Context:

  • Heat shock protein 90 (Hsp90) is a crucial chaperone protein involved in cancer cell survival and proliferation.
  • Telomerase activity and P53 expression are critical factors in human breast cancer progression.
  • Targeting Hsp90 is a potential therapeutic strategy for cancer treatment.

Purpose:

  • To investigate the effect of inhibiting Hsp90 function on telomerase activity and P53 expression in human breast cancer cells.
  • To evaluate the efficacy of geldanamycin (GA), an Hsp90 inhibitor, in modulating these factors.

Summary:

  • Geldanamycin (GA) treatment inhibited proliferation of MDA-MB-435s human breast cancer cells in a time- and dose-dependent manner.
  • GA induced G2/M cell cycle arrest and significantly decreased telomerase activity.
  • GA treatment also reduced the expression of mutant P53 protein in these cells.

Impact:

  • Hsp90 function is directly related to telomerase activation and mutant P53 expression in MDA-MB-435s cells.
  • Inhibiting Hsp90 with GA offers a potential therapeutic approach by decreasing telomerase activity and mutant P53 expression.
  • This inhibition ultimately represses human breast cancer cell proliferation.

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.